HEMOPHILIA B
Clinical trials for HEMOPHILIA B explained in plain language.
Never miss a new study
Get alerted when new HEMOPHILIA B trials appear
Sign up with your email to follow new studies for HEMOPHILIA B, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Two-Year look at hemophilia b treatment in everyday life
Disease control CompletedThis study observed how patients with hemophilia B used the extended-release clotting factor Alprolix in real-world settings over two years. Researchers tracked bleeding rates, injection frequency, and medication usage in 151 patients who were already prescribed this treatment. T…
Matched conditions: HEMOPHILIA B
Sponsor: Swedish Orphan Biovitrum • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Patients and doctors share views on new gene therapy for bleeding disorder
Knowledge-focused CompletedThis study surveyed 150 hemophilia B patients, their caregivers, and healthcare workers worldwide to understand what they know and think about gene therapy. Researchers conducted interviews to learn about people's attitudes, concerns, and how they prefer to receive information ab…
Matched conditions: HEMOPHILIA B
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC
-
Scientists gather data to pave way for hemophilia gene therapy
Knowledge-focused CompletedThis study aimed to collect detailed information on how well current standard treatments work for adults with severe hemophilia A or B. Researchers tracked bleeding rates and treatment use in 212 participants for at least six months. This data serves as a crucial baseline to comp…
Matched conditions: HEMOPHILIA B
Phase: PHASE3 • Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:37 UTC